Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127410572 | 12741057 | 2 | F | 20160725 | 20160912 | 20160914 | 20160922 | PER | PHEH2016US022639 | NOVARTIS | 69.92 | YR | M | Y | 0.00000 | 20160922 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127410572 | 12741057 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | 21588 | 400 | MG | QD | |||||||
| 127410572 | 12741057 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | U | 0 | ||||||||||
| 127410572 | 12741057 | 3 | C | CITRACAL | CALCIUM CITRATE | 1 | Unknown | U | 0 | ||||||||||
| 127410572 | 12741057 | 4 | C | YEAST | YEAST | 1 | Unknown | U | 0 | ||||||||||
| 127410572 | 12741057 | 5 | C | FLAXSEED | FLAX SEED | 1 | Unknown | U | 0 | ||||||||||
| 127410572 | 12741057 | 6 | C | MAGNESIUM | MAGNESIUM | 1 | Unknown | U | 0 | ||||||||||
| 127410572 | 12741057 | 7 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 127410572 | 12741057 | 8 | C | GLUCOSAMINE CHONDROITIN /01430901/ | 2 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127410572 | 12741057 | 1 | Gastrointestinal stromal tumour |
| 127410572 | 12741057 | 2 | Atrial fibrillation |
| 127410572 | 12741057 | 3 | Mineral supplementation |
| 127410572 | 12741057 | 4 | Product used for unknown indication |
| 127410572 | 12741057 | 5 | Product used for unknown indication |
| 127410572 | 12741057 | 6 | Product used for unknown indication |
| 127410572 | 12741057 | 7 | Product used for unknown indication |
| 127410572 | 12741057 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127410572 | 12741057 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127410572 | 12741057 | Asthenia | |
| 127410572 | 12741057 | Dyspnoea | |
| 127410572 | 12741057 | Fatigue | |
| 127410572 | 12741057 | Gastrointestinal haemorrhage | |
| 127410572 | 12741057 | Incorrect product storage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127410572 | 12741057 | 1 | 2010 | 201609 | 0 |